Gaush Meditech Ltd

Research Gaush Meditech Ltd (F7Y) on Bullrun: market cap EUR 73.06M, P/E 5.5. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is EUR 73.06M; P/E is 5.5.

Peer valuation comparison

Latest P/E is 5.49x versus a Healthcare sector median of 24.46x (77.6% below).

Latest P/E is 5.49x versus a China median of 10.67x (48.6% below).

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025CNY 1.38BCNY 96.19MCNY 110.47M45.9%n/aCNY 437.66MCNY 507.15MCNY 1.69B
FY2024CNY 1.43BCNY 92.39MCNY 26.57M46.4%0.63CNY 421.44MCNY 552.24MCNY 1.58B
FY2023CNY 1.41BCNY 173.52MCNY 203.44M49.2%1.17CNY 618.70MCNY 664.36MCNY 1.68B
FY2022CNY 1.25B-CNY 349.62MCNY 186.41M49.9%-3.61CNY 721.52MCNY 756.00MCNY 1.47B
FY2021CNY 1.30B-CNY 190.45MCNY 136.44M46.9%-1.99CNY 609.00MCNY 961.28M-CNY 656.43M

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-08-25EUR 73.06M5.56.0%0.03

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0.03 EUR.

YearDividends/share
FY20250.03 CNY
FY20240.12 CNY

About Gaush Meditech Ltd

Gaush Meditech Ltd. engages in research and development, production, and distribution of ophthalmic medical equipment and consumables, and the provision of technical services to end customers.

Related stock research

Other Healthcare stocks

Frequently asked questions

What is Gaush Meditech Ltd's market cap?

Gaush Meditech Ltd's market capitalization is EUR 73.06M.

What is Gaush Meditech Ltd's P/E ratio?

Gaush Meditech Ltd's price-to-earnings (P/E) ratio is 5.5.

What does Gaush Meditech Ltd do?

Gaush Meditech Ltd. engages in research and development, production, and distribution of ophthalmic medical equipment and consumables, and the provision of technical services to end customers.